MedPath

Beneficial Antipsychotic Effects of Celecoxib Add – on Therapy Compared to Clozapine Alone in Schizophrenia

Phase 2
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT201301095280N11
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

diagnosis of schizophrenia based on DSM-IV criteria; not using long acting antipsychotics since the last month; not using any oral antipsychotic except clozapine since the last week. Exclusion criteria: any side effects of drugs; need to changing antipsychotic drugs or adding new one.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Schizophrenia. Timepoint: Baseline, 2nd, 4th weeks. Method of measurement: PANSS test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath